Skip to main content

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Submitted by kassing on Tue, 09/10/2024 - 12:05
  • Read more about MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Submitted by kassing on Tue, 09/10/2024 - 12:05
  • Read more about Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Submitted by kassing on Tue, 09/10/2024 - 12:04
  • Read more about Hydrops: Diagnosing & Redefining Outcomes With Precision Study

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Submitted by kassing on Tue, 08/27/2024 - 19:24
  • Read more about A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Submitted by kassing on Tue, 08/27/2024 - 19:24
  • Read more about Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Submitted by kassing on Tue, 08/27/2024 - 19:24
  • Read more about Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

Submitted by kassing on Tue, 08/27/2024 - 19:24
  • Read more about MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study

US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Submitted by kassing on Tue, 08/27/2024 - 19:23
  • Read more about US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Submitted by kassing on Tue, 08/27/2024 - 19:23
  • Read more about Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Lysosomal Acid Lipase (LAL) Deficiency Registry

Submitted by kassing on Tue, 08/27/2024 - 19:22
  • Read more about Lysosomal Acid Lipase (LAL) Deficiency Registry

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next
  • Last page Last
Subscribe to